755303
3-Amino-2-fluoropropionic acid
95%
Synonym(s):
DL-2-Fluoro-β-alanine
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C3H6FNO2
CAS Number:
Molecular Weight:
107.08
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Recommended Products
Assay
95%
form
solid
mp
240-245 °C
SMILES string
NCC(F)C(O)=O
InChI
1S/C3H6FNO2/c4-2(1-5)3(6)7/h2H,1,5H2,(H,6,7)
InChI key
OJQNRNQELNLWHH-UHFFFAOYSA-N
Related Categories
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
K Okuno et al.
Cancer chemotherapy and pharmacology, 42(4), 341-344 (1998-09-23)
The aim of this study was to identify the route of administration of 5-FU with the greatest pharmacological advantage in a rat model using non-invasive in vivo 19F nuclear magnetic resonance (NMR) spectroscopy. 5-FU (50 mg/kg) was administered to anesthetized
Bruno Reigner et al.
Cancer chemotherapy and pharmacology, 52(3), 193-201 (2003-06-05)
Capecitabine (Xeloda) is a novel, oral fluoropyrimidine carbamate rationally designed to generate 5-fluorouracil (5-FU) preferentially in tumor tissue via a three-step enzymatic cascade. The objective of this study was to compare the pharmacokinetics of capecitabine and its metabolites in Japanese
Woo Young Kim et al.
Cancer science, 98(10), 1604-1608 (2007-08-09)
We studied whether total gastrectomy for gastric cancer would affect the pharmacokinetics of 5-fluorouracil (5-FU) and its degradation products, such as dihydrouracil (FUH(2)) and alpha-fluoro-beta-alanine (FBAL), after oral administration of the fluorouracil derivative S-1, composed of tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP; a
S Ndaw et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(27), 2630-2634 (2010-03-09)
A new sensitive and specific HPLC-MS/MS method for the determination of α-fluoro-β-alanine (FBAL), the main metabolite of the antineoplastic drug 5-fluorouracil (5-FU), in urine for the biological monitoring survey of health care workers exposed to 5-FU is described. This procedure
Onne Creten et al.
American journal of ophthalmology, 142(1), 194-196 (2006-07-04)
The aim of this study is to determine if systemic absorption is present after 5-fluorouracil (5FU) is used in the vitrectomy infusion. A two-case clinical study. A catabolite of 5FU, alpha-fluoro-beta-alanine (FBAL), was measured in urine samples of two patients
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service